2 Beaten-Down Stocks to Buy on the Dip
Investors haven't been kind to Intuitive Surgical (NASDAQ: ISRG) and Regeneron Pharmaceuticals (NASDAQ: REGN) this year. Both healthcare leaders have encountered company-specific issues that have led to sell-offs. Intuitive Surgical's stock is down 15% this year, while Regeneron has shed 21% of its value.
However, there are excellent reasons to think both companies could rebound, and if that's the case, now might be a wonderful time to purchase their shares on the dip. Here's why I remain bullish on these medical companies.
Image source: Getty Images.
Source Fool.com
Regeneron Pharmaceuticals Inc. Aktie
475,90 €
-1,22 %
Klare Kaufstimmung für Regeneron Pharmaceuticals Inc.: Viel mehr Buy- als Sell-Einschätzungen.
Für Regeneron Pharmaceuticals Inc. sieht die Community ein Kursziel von 854 €, was eine erhebliche Steigerung um über 50% gegenüber dem aktuellen Kurs von 475.9 € bedeutet.
